FDA scientists appear poised to sign off on the company’s proposal, according to a preliminary review posted by the agency ...

Altria relies on cigarettes as vapes face bans, flavors grow and on! competes with ZYN, with low multiple and 7.5% dividend appeal. Read why MO stock is a buy.

MO is making steady progress in the smoke-free transition, with oral nicotine gaining traction as it reshapes the business ...

Altria Group (MO) shares continued gains for seven straight sessions, as the stock closed 0.42% higher at $61.84 on Friday. The Marlboro maker’s shares gained over 10% in the preceding six sessions.